VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients

<div>VSNL1 expression in gastric cancer patients. (a–d) The relative level of VSNL1 mRNA was significantly higher in gastric cancer than normal tissues. All data collection and statistical analyses were performed on the Oncomine platform (<a href="https://www.oncomine.org">https://www.oncomine.org</a>).</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients 

Figure 1 | VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients 